In August 2018 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the wrestler J-5974 after his A and B samples tested positive for the prohibited substance Acetazolamide. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel (JADDP).
The Athlete accepted the test results and denied the intentional use of the prohibited substance. He believed that the positive test result was caused by a contaminated medication he had used prescribed by the team physician. Analysis of this medication confirmed that it contained the prohibited substance while the substance was not listed as ingredient on the label of this product.
Considering the evidence in this case the Panel accepts that the positive test was the result of a prescribed contaminated medication the Athlete had used and that he established No Fault or Negligence.
Therefore the JADDP decides on 22 February 2019 to lift the provisional suspension and to acquit the Athlete J-5974 without imposing any period of ineligibility.
